T
Tarsus Pharmaceuticals
TARS
23.450
USD
-0.78
(-3.22%)
مغلق
حجم التداول
8,198
الربح لكل سهم
0
العائد الربحي
0
P/E
-10
حجم السوق
1,690,574,792
العنوان: Tarsus Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.